Laboratory and echocardiographic changes at chronic heart failure in women with overweight and obesity depending on functional class of disease

Authors

DOI:

https://doi.org/10.15587/2313-8416.2015.53889

Keywords:

laboratory changes, echocardiography, chronic heart failure, functional class, women, obesity

Abstract

The half of all patients with CHF is women most of them has a preserved ejection fraction (EF) of the left ventricle (LV) and near 35% of their death from cardiovascular pathology are caused by CHF. The aim of research was the study of changes of laboratory and echocardiographic parameters at CHF in women with overweight and obesity depending on the functional class (FC) of disease.

Methods: There were examined 203 women with CHF of 1–111 FC with overweight and abdominal obesity of 1–111 degree. All patients underwent laboratory and echocardiographic examination. Processing of received results was carried out using parametric and nonparametric statistics depending on size and distribution of parameters.

Results: At CHF progress the level of hemoglobin, erythrocytes, lymphocytes, prothrombin, albumin in blood and the speed of glomerular filtration decrease. The content of segmented neutrophils, creatinine and urea, speed of erythrocytes sedimentation increases. The structural changes of myocardium and valvate apparatus are presented as the more significant dilatation of heart cameras, progress of LV hypertrophy, calcination and regurgitation of valves. At CHF progress the changes of myocardium functional state are characterized with formation of systolic and diastolic LV dysfunction of the 1 type and with the spread of its combination and progress of pulmonary hypertension. In most examined patients the remodeling of myocardium is presented as concentric LV hypertrophy which frequency decreases with growth of CHF FC at the expense of the spread of eccentric hypertrophy. The percent of concentric remodeling of LV decreases with CHF intensification.

Conclusions: With an increase of CHF FC in women with overweight and obesity take place the typical laboratory changes in blood, the structural reconstruction of the heart and disorder of myocardium functional state

Author Biography

Петро Петрович Бідзіля, Zaporozhye state medical university 26 Mayakovsky ave., Zaporozhye, Ukraine, 69035

Candidate of medical sciences, associate professor

Department of internal diseases 1

References

Ginghină, C., Botezatu, C. D., Șerban, M., Jurcuț, R. (2011). A personalized medicine target: heart failure in women. Journal of Medicine and Life, 4 (3), 280–286.

Galvao, M., Kalman, J., Demarco, T., Fonarow, G. C., Galvin, C., Ghali, J. K., Moskowitz, R. M. (2006). Gender Differences in In-Hospital Management and Outcomes in Patients With Decompensated Heart Failure: Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE). Journal of Cardiac Failure, 12 (2), 100–107. doi: 10.1016/j.cardfail.2005.09.005

Russo, C., Jin, Z., Palmieri, V., Homma, S., Rundek, T., Elkind, M. S. V. et. al (2012). Arterial Stiffness and Wave Reflection: Sex Differences and Relationship With Left Ventricular Diastolic Function. Hypertension, 60 (2), 362–368. doi: 10.1161/hypertensionaha.112.191148

Rebrov, A. P., Tplstov, S. N. (2011). Hendernye osobennosti remodelirovania serdtsa u bolnych khronicheskoi serdechnoi nedostatochnostyu ishemicheskoi etiolohii [Gender characteristics of heart remodeling in patients with chronic heart failure of ischemic etiology]. Vesnik sovremennoi klinicheskoi meditsyny, 4 (2), 22–25.

Blauwet, L. A., Hayes, S. N., McManus, D., Redberg, R. F., Walsh, M. N. (2007). Low Rate of Sex-Specific Result Reporting in Cardiovascular Trials. Mayo Clinic Proceedings, 82 (2), 166–170. doi: 10.4065/82.2.166

Klabnik, A., Murin, Ya. (2013). Khronichna serceva nedostatnist u zhinok: korotkyi ohliad z akzentom na novykh markerakh yakosti terapii [Chronic heart failure in women: short review with accent on new markers of quality of therapy]. Liky Ukrainy, 7 (173), 80–83.

Voronkov, L. H. (2015). Anemiya u patsienta s KHSN: kak otsenivat i lechit? [Anemia in patient with CHF: how to evaluate and treat?]. Serdechnaia nedostatochnost, 2, 5–14.

Hlushko, L. V., Fedorov, S. V. (2014). Kilkist leikotsitov ta pokaznyky leikotsytarnyh indeksiv pry sercevii nedostatnosti [The number of leukocytes and leukocytic indices of indices in heart failure]. Klinichna ta eksperimentalna patolohia, XIIІ/3 (49), 51–54.

Charach, G., Grosskopf, I., Roth, A., Afek, A., Wexler, D., Sheps, D. et. al (2011). Usefulness of Total Lymphocyte Count as Predictor of Outcome in Patients With Chronic Heart Failure. The American Journal of Cardiology, 107 (9), 1353–1356. doi: 10.1016/j.amjcard.2010.12.049

Voronkov, L. H. et. al (2013). Rekomndacii po diahnostike I lecheniu khronicheskoi serdechnoi nedostatochnosti (2012) [Guidelines for the diagnosis and treatment of chronic heart failure (2012)]. Ukrainian cardiology journal, 1, 6–44.

Rundneva, E. A. (2008). Nadlezhashaia klinicheskaia praktika I issledovatel. Obshie princypy GCP ICH. [Good clinical practice and the researcher. General principles of ICH GCP]. Ukr. med. chasopys, 1 (63), 49–56.

Published

2015-11-27

Issue

Section

Medical